Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414
Almost a year after Raymond James purchased Morgan Keegan , the integration has passed its last major milestone, which means the end of the venerable Morgan Keegan brand. The final integration will make Raymond James one of the largest brokerage firms behind the four wirehouses with almost 6,300 ...
Morgan Keegan & Co. is going to trial before a judge whose decision to throw out regulators' claims the retail brokerage misled thousands of investors about the risks of auction-rate securities was reversed on appeal.
Eight former directors overseeing mutual funds for Morgan Keegan & Co. settled, without paying any penalties, U.S. regulatory claims that they allowed assets backed by subprime mortgages to be overvalued as the housing market collapsed in 2007.
Eight former Morgan Keegan & Co. mutual-fund directors agreed to settle U.S. regulatory claims that they allowed assets backed by subprime mortgages to be overvalued as the housing market collapsed in 2007.
The Regions Morgan Keegan Funds were charged by the SEC with overstating the value of their securities as the housing market was collapsing in 2007.
Raymond James Financial plans to drop Morgan Keegan from the name of its fixed income arm later this month.
Raymond James said Tuesday it had wrapped up the conversion of Morgan Keegan operations and clients into Raymond James’ technology systems.
Also in the SEC's crosshairs recently: A penny-stock promoter nabbed in an undercover FBI sting and two medical insurance execs accused of a Ponzi scheme.
The Securities and Exchange Commission has initiated cease-and-desist proceedings against the former board members of five registered investment firms, alleging that they failed to maintain appropriate fair-market valuations of debt securities that comprised a substantial portion of the companies' ...